Cancer drug price spikes 1,400% with no generic option

1,319 views · Published 2 January 2018 · 6:09 · Indexed 20 September 2026

Channel: CBS News · 2018 · News & Politics

Watch on YouTube

For cancer patients, the medications they take are crucial to survive. A Wall Street Journal report looks into price-gouging, specifically on the brain cancer drug lomustine. Reporter Peter Loftus joins CBSN to talk about his article and the issues this creates for patients.

More from this channel